Budesonide/Glycopyrronium/Formoterol
Treatment for Chronic Bronchitis
Typical Dosage: Specific to combination (e.g., Budesonide 160mcg / Glycopyrronium 7.2mcg / Formoterol 4.8mcg twice daily)
Effectiveness
82%
Safety Score
50%
Clinical Trials
15
Participants
15K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Dosage Range
Specific to combination (e.g., Budesonide 160mcg / Glycopyrronium 7.2mcg / Formoterol 4.8mcg twice daily)
Time to Effect
Weeks to months
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$6,500
Monitoring:$600
Side Effect Mgmt:$200
Total Annual:$7,300
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATEICER
$110,000/QALY
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$9,125
Cost per Remission
$146,000
Comparison vs ICS/LABA (e.g., Fluticasone/Salmeterol)
Cost Difference
+$2,500/year
More expensive
QALY Difference
+0.08 QALYs
Better outcomes
Dominance
No dominance
Budesonide/Glycopyrronium/Formoterol Outcomes
for Chronic Bronchitis
Efficacy Outcomes
Overall Effectiveness
+82%
Response Rate
+80%
Remission Rate
+5%
Common Side Effects
Nasopharyngitis
+7%
Oral candidiasis
+4%
Pneumonia
+4%
Headache
+5%
Urinary tract infection
+2.5%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov